Going beyond other study methods, Sharff found a number of vaccine myocarditis cases that weren’t explicitly labelled as such or were outside the parameters of the CDC’s vaccine safety search. After performing an exhaustive search of the Kaiser medical records, Sharff and colleagues found a 1 in 1,862 rate of myocarditis after the second dose in young men ages 18 to 24. For boys ages 12 to 17, the rate was 1 in 2,650. Countries with active surveillance monitoring of medical data (which suffer from far less under-reporting than the passive system in the U.S)—such as Hong Kong—show virtually identical figures. The risk of vaccine-induced myocarditis remains elevated for men up to the age of 40.

Historically, vaccines with adverse event profiles far lower — but still deemed far too high — than the mRNA myocarditis signal have been withdrawn. The 1976 swine flu vaccine was pulled back because of a 1 in 100,000 risk of Guillain-Barre Syndrome.

Using Covid hospitalization statistics instead of deaths is a more accurate comparison since Covid deaths are virtually nonexistent in healthy, young populations. Still, the differences are massive. For example, the risk of myocarditis from dose one in males ages 18-24 is 15 times higher than hospitalization from Covid re-infection. For dose two, the risk differential is a stunning 61 times greater.Unless a young male is immunocompromised, obese, or suffering from other serious health conditions, taking any mRNA Covid vaccines carries far more risk than benefit. The best data indicate this is a fact — though this is hardly considered in mainstream media.

In light of the FDA and CDC’s outrageous push to vaccinate everyone with the new “bivalent” booster—despite explicitly “unknown” myocarditis risks—hopefully more people will wake up and re-evaluate their blind faith in institutions who have far abandoned their ostensible mission of keeping us safe and healthy.

rwmalonemd Tragic: 14-Year Old Vaccine Myocarditis Victim